Saba Capital Management, L.P. sold HQL
September 18, 2025 · Form 4 insider transaction
Saba Capital Management, L.P. sold 40,208 shares of Abrdn Life Sciences Investors at $14.07 per share, a transaction worth $565.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
40,208
Price
$14.07
Total value
$565.7K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 18, 2025
Filing dateSeptember 19, 2025
Shares owned after2,886,245
OwnershipIndirect
10b5-1 planNo
AmendedNo